Adam Kadlec

Chief Executive Officer at Rivermark Medical, Inc.

Consumer Services

Finance

Health Technology

Profile

Adam Kadlec is currently the President, Chief Executive Officer & Director at Rivermark Medical, Inc. and an Advisor at Golden Angels Investors LLC since 2018.
He completed his undergraduate and graduate degrees at the University of Wisconsin.

Adam Kadlec active positions

Companies	Position	Start
Golden Angels Investors LLC Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin.	Consultant / Advisor	2018-03-31
Rivermark Medical, Inc. Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec.	Chief Executive Officer	2021-07-31

All active positions of Adam Kadlec

Training of Adam Kadlec

University of Wisconsin

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Adam Kadlec's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	2
Golden Angels Investors LLC Golden Angels Investors LLC Investment ManagersFinance Golden Angels Investors LLC (Golden Angels Investors) is a venture capital firm founded in 2002 by Timothy J Keane. The firm is headquartered in Brookfield, Wisconsin.	Finance
Rivermark Medical, Inc. Rivermark Medical, Inc. Medical SpecialtiesHealth Technology The American company was founded by a practicing urologist with the aim of developing the preferred first-line device therapy for benign prostatic hyperplasia. The company's flagship product, the Flostent system, enables physicians to treat patients safely and efficiently, with minimal discomfort and reduced complications. Rivermark Medical plans to bring the Flostent system to market as their first product. The CEO of the company is Adam Kadlec.	Health Technology